Supreme Court's Wal-Mart Ruling Could Curtail Pharma Gender Discrimination Cases
Executive Summary
The attorneys who won a gender discrimination suit against Novartis Pharmaceuticals Corp. said they would have had a tough time prevailing if they'd gone to court after the Supreme Court's ruling in the Wal-Mart gender discrimination class action.
You may also be interested in...
Gender Discrimination Suits: Cases Against Pharma Continue Even As Payouts Slow
Novartis will pay $8m to settle second case; last year Daiichi Sankyo settled gender discrimination class action for the same amount and action against Bayer was dismissed following confidential resolution. Cases are ongoing against Merck and Forest.
Merck Gender Discrimination Class Action Alleges Maternity Leave Leads To Manager Pay Cuts
Merck is the sixth pharmaceutical company to be hit with a sales rep gender discrimination class action by Sanford Heisler; similar complaints have survived motions to dismiss filed in wake of Supreme Court’s Wal-Mart v. Dukes ruling.
Bayer Gender Discrimination Suit Cites Internal Articles, Bidding Process For Advancement
Plaintiffs firm that won jury verdict in similar class action against Novartis is seeking $100 million or more in damages.